Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04710212 · ClinicalTrials.gov registry record
Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 168
- Enrollment target
NCT04710212: Completed study, sponsored by Duke University.
NCT04710212 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 168 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04710212 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 168 participants
- Enrollment target
Study Summary
This is a prospective, observational cohort study to assess the frequency with which neutropenic patients with hematologic malignancies and hematopoietic cell transplant (HCT) recipients are colonized with fluoroquinolone-resistant Enterobacterales (FQRE) and the clinical impact of FQRE colonization.
Primary Outcome
Gram-negative BSI during the episode of neutropenia
Interventions
- OTHER No intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2021-03-12 |
| Est. Completion | 2022-02-28 |
What the finished NCT04710212 record still lists
NCT04710212 is an observational study that tracks outcomes without assigning an intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention. is the first listed.
NCT04710212 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04710212 about?
NCT04710212 is a clinical study titled "Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies". This is a prospective, observational cohort study to assess the frequency with which neutropenic patients with hematologic malignancies and hematopoietic cell transplant (HCT) recipients are colonized with fluoroquinolone-resistant Enterobacterales (FQRE) and the clinical impact of FQRE colonization...
What is the current status of trial NCT04710212?
This trial is currently completed. The enrollment target is 168 participants. The study started on 2021-03-12. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT04710212?
The interventions under investigation include: No intervention. (OTHER).
Who is sponsoring clinical trial NCT04710212?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI